Sentinel lymph node detection rates, histopathological findings, and anatomical localizations
| Variables | N (%) |
| Patients who underwent SLN assessment | 268 |
| Overall detection rate* | 255 (95.1) |
| Successful bilateral mapping | 225 (84.0) |
| Bilateral mapping failure | 13 (4.9) |
| Anatomical localization | |
| Right hemipelvis | |
| External iliac vessels/obturatory vessels | 223 (94.5) |
| Common/internal iliac vessels | 13 (5.5) |
| Left hemipelvis | |
| External iliac vessels/obturatory vessels | 241 (98.4) |
| Common/internal iliac vessels | 4 (1.6) |
| Endometrial cancer patients and SLN assessment | 163 |
| Overall detection rate* | 157 (96.3) |
| Successful bilateral mapping | 136 (83.4) |
| Bilateral mapping failure | 6 (3.7) |
| Patients with lymph node metastasis† | 12 (7.6)‡ |
| SLN histological status | |
| Negative | 145 (92.4) |
| Positive | 12 (7.6) |
| Positive SLN histology | |
| ITC | 1 (8.3) |
| Micrometastasis | 9 (75.0) |
| Macrometastasis | 2 (16.7) |
Values shown as n (%) unless stated otherwise.
*Detection of at least one SLN.
†Rates calculated in patients with at least monolateral mapping (n=157).
‡One patient reported a positive pelvic sentinel lymph node and a metastatic bulky para-aortic lymph node. ITCs were not considered among metastatic lymph nodes.
ITC, isolated tumor cells; SLN, sentinel lymph node.